Literature DB >> 19752305

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

Massimiliano Calabrese1, Federica Agosta, Francesca Rinaldi, Irene Mattisi, Paola Grossi, Alice Favaretto, Matteo Atzori, Valentina Bernardi, Luigi Barachino, Luciano Rinaldi, Paola Perini, Paolo Gallo, Massimo Filippi.   

Abstract

BACKGROUND: Neuropsychological deficits in patients with multiple sclerosis (MS) have been shown to be associated with the major pathological substrates of the disease, ie, inflammatory demyelination and neurodegeneration. Double inversion recovery sequences allow cortical lesions (CLs) to be detected in the brain of patients with MS. Modern postprocessing techniques allow cortical atrophy to be assessed reliably.
OBJECTIVE: To investigate the contribution of cortical gray matter lesions and tissue loss to cognitive impairment in patients with relapsing-remitting MS.
DESIGN: Cross-sectional survey.
SETTING: Referral, hospital-based MS clinic. Patients Seventy patients with relapsing-remitting MS. MAIN OUTCOME MEASURES: Neuropsychological performance was tested using the Rao Brief Repeatable Battery of Neuropsychological Tests, version A. Patients who scored 2 SDs below the mean normative values on at least 1 test of the Rao Brief Repeatable Battery of Neuropsychological Tests, version A, were considered to be cognitively impaired. A composite cognitive score (the cognitive impairment index) was computed. T2 hyperintense white matter lesion volume, contrast-enhancing lesion number, CL number and volume, normalized brain volume, and normalized neocortical gray matter volume were also assessed.
RESULTS: Twenty-four patients with relapsing-remitting MS (34.3%) were classified as cognitively impaired. T2 hyperintense white matter lesion volume and contrast-enhancing lesion number were not different between cognitively impaired and cognitively unimpaired patients. Cognitively impaired patients had a higher CL number (P = .01) and volume (P < .001) and decreased normalized brain volume (P = .02) and normalized neocortical gray matter volume (P = .002) when compared with cognitively unimpaired patients. Multivariate analysis revealed that age (beta = 0.228; P = .02), CL volume (beta = 0.452; P < .001), and normalized neocortical gray matter volume (beta = 0.349; P < .001) were independent predictors of the cognitive impairment index (r(2) = 0.55; F = 23.903; P < .001).
CONCLUSION: The burden of CLs and tissue loss are among the major structural changes associated with cognitive impairment in relapsing-remitting MS.

Entities:  

Mesh:

Year:  2009        PMID: 19752305     DOI: 10.1001/archneurol.2009.174

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  163 in total

1.  Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report.

Authors:  F Rinaldi; M Calabrese; D Seppi; M Puthenparampil; P Perini; P Gallo
Journal:  Neurol Sci       Date:  2011-01       Impact factor: 3.307

2.  Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data.

Authors:  Menno M Schoonheim; Jeroen J G Geurts; Doriana Landi; Linda Douw; Marieke L van der Meer; Hugo Vrenken; Chris H Polman; Frederik Barkhof; Cornelis J Stam
Journal:  Hum Brain Mapp       Date:  2011-09-23       Impact factor: 5.038

3.  Brain networks disconnection in early multiple sclerosis cognitive deficits: an anatomofunctional study.

Authors:  Céline Louapre; Vincent Perlbarg; Daniel García-Lorenzo; Marika Urbanski; Habib Benali; Rana Assouad; Damien Galanaud; Léorah Freeman; Benedetta Bodini; Caroline Papeix; Ayman Tourbah; Catherine Lubetzki; Stéphane Lehéricy; Bruno Stankoff
Journal:  Hum Brain Mapp       Date:  2014-03-31       Impact factor: 5.038

Review 4.  Causes, effects and connectivity changes in MS-related cognitive decline.

Authors:  Carolina de Medeiros Rimkus; Martijn D Steenwijk; Frederik Barkhof
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar

Review 5.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 6.  Grey matter damage in multiple sclerosis: a pathology perspective.

Authors:  Roel Klaver; Helga E De Vries; Geert J Schenk; Jeroen J G Geurts
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 7.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

Review 8.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

9.  Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.

Authors:  Denis Peruzzo; Marco Castellaro; Massimiliano Calabrese; Elisa Veronese; Francesca Rinaldi; Valentina Bernardi; Alice Favaretto; Paolo Gallo; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-19       Impact factor: 6.200

10.  Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.

Authors:  R Vitorino; S-P Hojjat; C G Cantrell; A Feinstein; L Zhang; L Lee; P O'Connor; T J Carroll; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.